George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.30
Bid: 52.24
Ask: 52.26
Change: 1.10 (2.15%)
Spread: 0.02 (0.038%)
Open: 51.12
High: 52.60
Low: 51.08
Prev. Close: 51.20
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

22 Feb 2024 07:00

RNS Number : 9936D
Lloyds Banking Group PLC
22 February 2024
 

22 February 2024

LLOYDS BANKING GROUP: BOARD CHANGES

Lloyds Banking Group plc ("Group") announces that Alan Dickinson, having served nine years as a non-executive director as of September 2023, has informed the Board that he intends to step down as Deputy Chair and a non-executive director of the Group at its 2024 annual general meeting.

The Group is pleased to announce that Nathan Bostock will be appointed a non-executive director of the Group and, subject to regulatory approval, Chair of Lloyds Bank Corporate Markets plc, in each case with effect from 1 August 2024. Nathan was Chief Executive Officer of Santander UK from 2014 until 2022. Prior to joining Santander, Nathan was an executive director and Group Chief Financial Officer of The Royal Bank of Scotland plc ("RBS") and previously held the post of Chief Risk Officer at RBS.

Sir Robin Budenberg, Group Chair, said "We will miss the enormous contribution Alan has made to the Group over many years including long-term roles on all our committees and spells as Chair of the Risk and Remuneration Committees. The tremendous insights he has brought to his roles have been particularly valued during a tenure as Deputy Chair and Senior Independent Director which has included Chair and Group Chief Executive successions and the challenges created by the COVID-19 pandemic and the ongoing cost of living increases. At the same time, we look forward to welcoming Nathan to the Group. Nathan brings extensive capital markets and wider financial services experience, in particular from his chief executive and chief risk officer roles. His deep knowledge of the UK banking market will be invaluable to his roles with the Group."

Further information on Nathan Bostock is set out below. There is no other information to be disclosed under paragraph 9.6.13R of the Listing Rules in relation to Nathan's appointment.

Biographical details

Nathan Bostock was Chief Executive Officer of Santander UK from 2014 until 2022 and then Head of Investment Platforms at Banco Santander until his retirement from Santander last year. Prior to joining Santander, Nathan was an executive director and Group Chief Financial Officer of RBS and previously held the post of Chief Risk Officer at RBS. Before joining RBS, Nathan was an executive director of Abbey National plc (now Santander UK) from 2005 until 2009. He held a number of senior positions at Abbey National plc including CEO - Financial Markets and Corporate Banking, CEO - Financial Markets and Portfolio Business Unit and Chief Operating Officer - Abbey National Treasury Services.

Nathan Bostock is currently a non-executive director of Centrica plc and Chair of its Audit and Risk Committee. Nathan is a chartered accountant.

- END -

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

 

+44 (0) 7788 352 487

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEUFMFELSEIE
Date   Source Headline
26th Apr 20245:28 pmRNSTransaction in Own Shares
25th Apr 20245:50 pmRNSTransaction in Own Shares
25th Apr 20241:14 pmRNSPublication of Suppl.Prospcts
24th Apr 20246:21 pmRNSTransaction in Own Shares
24th Apr 20242:37 pmRNSPublication of Suppl.Prospcts
24th Apr 202412:29 pmRNSPublication of Suppl.Prospcts
24th Apr 202411:03 amRNS2024 Q1 Interim Management Statement
24th Apr 20247:00 amRNS2024 Q1 Interim Management Statement
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.